A Clinical Trial Assessing The Impact Of Inhaled Insulin On Glucose Control In Patients With Type 2 Diabetes Mellitus

NCT00282971 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

354

Enrollment

INDUSTRY

Sponsor class

Stopped Terminated as marketing of this product will be discontinued

Conditions

Diabetes Mellitus Type 2

Interventions

DRUG: Inhaled Insulin (Exubera)
OTHER: Standard of Care

Sponsor

Pfizer